Structure, Mechanism and Crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
Authors:
- Joseph A NewmanJNJoseph A Newman
- Setayesh YazdaniSYSetayesh Yazdani
- Yuliana YosaatmadjaYYYuliana Yosaatmadja
- Anthony AimonAAAnthony Aimon
- Louise DunnettLDLouise Dunnett
- Tyler Gorrie-StoneTGTyler Gorrie-Stone
- Rachel SkynerRSRachel Skyner
- Daren FearonDFDaren Fearon
- Matthieu SchapiraMSMatthieu Schapira
- Frank von DelftFDFrank von Delft
Preprint
Abstract
The global COVID-19 pandemic is caused by the SARS-CoV-2 virus and has infected over 100 million and caused over 2 million fatalities worldwide at the point of writing. There is currently a lack of effective drugs to treat people infected with SARS-CoV-2. The SARS-CoV-2 Non-structural protein 13 (NSP13) is a superfamily1B helicase that has been identified as a possible target for anti-viral drugs due to its high sequence conservation and essential role in viral replication. In this study we present crystal structures of SARS-CoV-2 NSP13 solved in the APO form and in the presence of both phosphate and the non-hydrolysable ATP analogue (AMP-PNP). Comparisons of these structures reveal details of global and local conformational changes that are induced by nucleotide binding and hydrolysis and provide insights into the helicase mechanism and possible modes of inhibition. Structural analysis reveals two pockets on NSP13 that are classified as “druggable” and include one of the most conserved sites in the entire SARS-CoV-2 proteome. To identify possible starting points for anti-viral drug development we have performed a crystallographic fragment screen against SARS-CoV-2 NSP13 helicase. The fragment screen reveals 65 fragment hits across 52 datasets, with hot spots in pockets predicted to be of functional importance, including the druggable nucleotide and nucleic acid binding sites, opening the way to structure guided development of novel antiviral agents.Keywords
All Related Versions
- Published version: Nature Communications, 12 (1), 1.
This publication has 36 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral HelicaseAntimicrobial Agents and Chemotherapy, 2012
- Mechanism of Nucleic Acid Unwinding by SARS-CoV HelicasePLOS ONE, 2012
- Towards automated crystallographic structure refinement with phenix.refineActa Crystallographica Section D Structural Biology, 2012
- XDSActa Crystallographica Section D Structural Biology, 2010
- Identifying and Characterizing Binding Sites and Assessing DruggabilityJournal of Chemical Information and Modeling, 2009
- Common Evolutionary Origin of Swapped-Hairpin and Double-Psi β BarrelsStructure, 2006
- A Complex Zinc Finger Controls the Enzymatic Activities of Nidovirus HelicasesJournal of Virology, 2005
- The Severe Acute Respiratory Syndrome (SARS) Coronavirus NTPase/Helicase Belongs to a Distinct Class of 5′ to 3′ Viral HelicasesJournal of Biological Chemistry, 2003
- Do aligned sequences share the same fold?Journal of Molecular Biology, 1997
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997